1. Home
  2. NEON vs CING Comparison

NEON vs CING Comparison

Compare NEON & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

HOLD

Current Price

$1.90

Market Cap

32.1M

Sector

Technology

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$4.94

Market Cap

26.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEON
CING
Founded
1997
2012
Country
Sweden
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.1M
26.8M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
NEON
CING
Price
$1.90
$4.94
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$6.00
$31.33
AVG Volume (30 Days)
212.9K
189.9K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.54
N/A
Revenue
$2,197,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$43.34
N/A
P/E Ratio
$3.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.72
$3.20
52 Week High
$29.90
$6.01

Technical Indicators

Market Signals
Indicator
NEON
CING
Relative Strength Index (RSI) 37.68 64.24
Support Level $1.85 $4.41
Resistance Level $1.96 $5.07
Average True Range (ATR) 0.09 0.36
MACD 0.03 0.05
Stochastic Oscillator 48.48 68.32

Price Performance

Historical Comparison
NEON
CING

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: